1. Home
  2. AIDX vs HOTH Comparison

AIDX vs HOTH Comparison

Compare AIDX & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$1.60

Market Cap

19.5M

Sector

Health Care

ML Signal

N/A

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.72

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIDX
HOTH
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
17.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AIDX
HOTH
Price
$1.60
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
56.6K
3.1M
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.69
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.45
$0.49
52 Week High
$14.09
$2.12

Technical Indicators

Market Signals
Indicator
AIDX
HOTH
Relative Strength Index (RSI) 22.69 46.62
Support Level $1.51 $0.49
Resistance Level $2.08 $0.80
Average True Range (ATR) 0.13 0.07
MACD 0.10 0.01
Stochastic Oscillator 25.00 61.33

Price Performance

Historical Comparison
AIDX
HOTH

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: